🔎 Trials Near Me

Akèy › Maladi fwa steatotik › Illinois

Etid klinik pou Maladi fwa steatotik nan Illinois

6 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan Illinois.

Vil nan Illinois

Tèks ofisyèl etid la (Anglè)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • University of Chicago Medical Center, Chicago
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Chicago
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Chicago
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Chicago
  • 89bio Clinical Study Site, Glenview
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT06419374

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • RUSH University Medical Center, Chicago
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou May 19, 2026 · NCT04054310

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Ap rekriteFaz 2
Laj 16 a 20 · Tout sèks · Mizajou Jan 21, 2026 · NCT06355310

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.